Preparation of Notch-4 Receptor Containing Quartz Crystal Microbalance Biosensor for MDA MB 231 Cancer Cell...

Area of Science:

• Biomedical Engineering
• Biosensing Technology
• Cancer Diagnostics

Background:

• Quartz crystal microbalance (QCM) is a sensitive biosensor for biomolecules and cells.
• Early cancer cell detection is vital for diagnosis and treatment.
• Surface molecule characterization is key for identifying specific cancer cells.

Purpose of the Study:

• To develop a QCM-based biosensor for the selective detection of breast cancer cells.
• To functionalize a QCM chip with nanoparticles and specific proteins for enhanced cell capture.
• To evaluate the sensor's affinity and selectivity for MDA MB 231 breast cancer cells.

Main Methods:

• Coating QCM chips with polymeric nanoparticles to increase surface area.
• Functionalizing the chip surface with specific proteins for targeted cell attachment.
• Culturing and applying breast cancer cells (MDA MB 231) and control fibroblast cells (L929) to the functionalized chip.
• Utilizing QCM's sensitive detection capabilities to identify cancer cells.

Main Results:

• The functionalized QCM system demonstrated high affinity for breast cancer cells.
• The sensor exhibited high selectivity in detecting MDA MB 231 cells, distinguishing them from L929 fibroblast cells.
• Successful preparation methods for QCM-based sensors for selective cancer cell detection were established.

Conclusions:

• The developed QCM-based biosensor offers a promising approach for the selective and sensitive detection of breast cancer cells.
• This technology has potential applications in cancer diagnostics, particularly for circulating or biopsy samples.
• The nanoparticle-enhanced, protein-functionalized QCM chip provides a robust platform for cancer cell characterization.